Klein | Frank, P.C.

Phone: 303-448-8884
Fax: 303-861-2449

Viagra online
XANAXadderall onlineLevitraPuppies for sale

Archive for fda recall

FDA Warns Bayer - False Advertising & Quality Control of YAZ

A popular contraceptive for women called Yaz (also known as Yasmin or generic Ocella), faces growing concerns in the medical field for its serious and lengthy list of side effects. These side effects include blood clots, stroke, and heart attack along with gall bladder disease and pancreatitis, all of which have been linked with women using […]

In F.D.A. Files, Claims of Rush to Approve Devices

By GARDINER HARRIS
An official at the Food and Drug Administration overruled front-line agency scientists and approved the sale of an imaging device for breast cancer after receiving a phone call from a Connecticut congressman, according to internal agency documents.
The legislator’s call and its effect on what is supposed to be a science-based approval process is […]

Defective Medical Device Decision in Medtronic MDL

On Monday, United States District Court Judge, Kyle entered an order dismissing all claims asserted in the Medtronic Sprint Fidelis Leads Mulitdistrict Litigation based upon the doctrine of preemption.   
 In re Medtronic, Inc. Sprint Fidelis Leads Products Liability Litigation, the court dismissed all 21 claims in the master complaint: (1) strict liability – failure to warn; (2) […]

FDA and A New Year’s Resolution That Might Not Be So Good For Your Health

By: Carrie R. Frank
 
 
The holidays are here, Thanksgiving, Christmas and Hanukkah, New Year’s celebrations. All times when food is in abundance and our waistlines are expanding. Many people put “weight loss” high on their list of New Year’s Resolutions but when the new treadmill starts to collect dust, people often look for a “quick fix” […]

Actavis Totowa Recalls all Drug Products from Little Falls Plant

Actavis Totowa Announces Voluntary Recall at the Retail Level of All Drug Products Manufactured at its Little Falls, New Jersey Facility

FOR IMMEDIATE RELEASE — Morristown, NJ, August 1, 2008 — Actavis Totowa LLC, a generic drug manufacturer, is announcing a voluntary recall, to the retail level, of all drug products manufactured at its Little Falls, […]

Denver Digitek Death Lawsuit Filed by Digitek Lawyers Klein | Frank, P.C

Digitek Death Lawsuit - Actavis Totowa Accused of Producing Dangerously Defective Digitek Heart Pills in Lawsuit Filed by Klein | Frank, P.C.
 
Denver, Colorado, August 1, 2008.  A lawsuit filed in United States District Court in Denver, Colorado on August 1, 2008 charges pharmaceutical company Actavis Totowa LLC with manufacturing and distributing defective Digitek
heart drug pills that […]

Digitek Digoxin Lawyers, Litigation and Frequent Questions

The manufacturer, Actavis Totowa, LLC has issued a press statement that responds, in part to frequently asked questions about the Digitek recall and the specific Digitek tablets that are at issue. Check your prescription for digoxin tablets manufactured by Actavis. The defective digoxin or Digitek products were distributed by:
Mylan Pharmaceuticals, Inc. under the […]

Gadolinium Deadlines for Lawsuits and Legal Rights

The first layer of statutes of limitations for certain gadolinium cases runs on June 6, 2008.  After this deadline, some cases may be time barred, and some individuals may forfeit their legal rights.   It is critical that you do not delay and that you contact a lawyer as quickly as possible.
If you think that you […]

Digitek Digoxin Recall Attorney Lawyer

Digitek® (digoxin tablets), a drug used to treat heart failure and abnormal heart rhythms has been linked to Digitalis toxicity. Digitalis toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia. Death can also result from excessive Digitalis intake.
If you or a loved one have taken Digitek and suffered any of […]

The Contract Dye Manufacturer’s Letter on Gadolinium

Manufacturers of Gadolinium-based contrast dyes issued a Dear Healthcare Professional letter to doctors about an addition of a WARNING and revisions to the WARNING section of the prescribing information for Gadolinium-based contrast agents used in Magnetic Resonance Imaging (MRI).
It reads:
Dear Healthcare Professional,
 
Post-marketing reports show that the use of these agents increases the risk of the development of a […]